Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI)

Skip to main content

Phase: II/III
Status: Not Recruiting

The purpose of the study is to investigate the safety and efficacy of transcatheter aortic valve implantation (TAVI) in patients with severe, symptomatic Aortic Stenosis (AS) at intermediate surgical risk by randomizing patients to either Surgical Aortic Valve Replacement (SAVR) or TAVI with the Medtronic CoreValve® System.

For more information about this clinical trial, including trial status, eligibility and full trial listing, visit www.clinicaltrials.gov.